POST SUMMARY: The model for pharma growth seems to be to merge or buy smaller biotech companies, but is this a viable business decision?
Category Archive: Bad practices
POST SUMMARY: Drug marketers may be wasting a lot of money trying to drive demand for their products because the current healthcare system is getting harder to navigate and it’s making it harder for patients to be “consumers of healthcare“.
POST SUMMARY: Among the big losers in Super Bowl advertising is Jublia who wasted $4.5 million dollars on air time that could have been better spent elsewhere.
POST SUMMARY: Too many pharma organizations still require sales force experience/management to qualify for senior marketing positions. However, in an era when reps are less effective is this requirement dated?
POST SUMMARY: Researchers find that nearly 70 percent of Americans are on at least one prescription drug, and more than half receive at least two prescriptions, but why medications are prescribed should not be determined by pharma pressure on medical/scientific guidelines.
If you want an example of just how far pharma is lagging in digital look no further than the Novartis Oncology lung cancer site.
POST SUMMARY: Tow stories in the media last week, including a cover story in Newsweek, take aim at pharma. While there is some good reporting most of the content continues to ignore how drugs are marketed today.
One of the questions I get asked and asked again is “why haven’t most pharma companies changes in their approach to DTC and digital marketing?”. The answer to this is complex, but at its heart most major consulting research has indicated that time and time again pharma is a laggard when it comes to change and hiring people who can really question current thinking when it comes to meeting the needs of consumers of healthcare.